MEG spectral analysis in subtypes of mild cognitive impairment

M E López1, P Cuesta, P Garcés

  • 1Laboratory of Cognitive and Computational Neuroscience (UCM-UPM), Centre for Biomedical Technology (CTB), Campus de Montegancedo s/n, Pozuelo de Alarcón, 28223, Madrid, Spain, meugenia.lopez@ctb.upm.es.

Insights

Mild cognitive impairment (MCI) subtypes show distinct brain activity patterns. Multidomain MCI patients exhibit slower brain waves, indicating a higher risk of progressing to dementia.

Area of Science:

  • Neuroscience
  • Cognitive Neurology
  • Biomagnetism

Background:

  • Mild cognitive impairment (MCI) represents a transitional phase between normal aging and dementia.
  • Previous research explored brain oscillatory activity in MCI, but differences between amnestic MCI subtypes remain unclear.
  • Understanding these differences is crucial for predicting disease progression and developing targeted interventions.

Purpose of the Study:

  • To investigate and compare the patterns of oscillatory magnetic activity in single-domain amnestic MCI (a-sd-MCI) and multidomain amnestic MCI (a-md-MCI) patients.
  • To correlate these brain activity patterns with neuropsychological test scores and hippocampal volumes.
  • To differentiate the neurophysiological profiles of MCI subtypes and their potential link to Alzheimer's disease progression.

Main Methods:

  • Magnetoencephalography (MEG) recordings were performed on 105 subjects during eyes-closed resting state.
  • Participants included 36 healthy controls, 33 a-sd-MCI patients, and 36 a-md-MCI patients.
  • Relative power values in different frequency bands (delta, theta, alpha, beta) were calculated and compared across groups, then correlated with clinical data.

Main Results:

  • Both MCI groups exhibited increased power in lower frequencies (delta, theta) and decreased power in higher frequencies (alpha, beta) compared to controls.
  • A significant distinction was observed between MCI subtypes: a-md-MCI showed more pronounced power increases in delta/theta and decreases in alpha/beta.
  • These brain activity alterations in a-md-MCI correlated with poorer neuropsychological performance, suggesting a more severe cognitive status.

Conclusions:

  • The a-md-MCI subtype displays a distinct brain activity profile characterized by "slowing" of the spectrum, more akin to Alzheimer's disease.
  • This neurophysiological pattern in a-md-MCI is associated with diminished cognitive function.
  • Findings suggest a potentially higher likelihood of conversion to dementia in the a-md-MCI group compared to the a-sd-MCI group.

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
1.1K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35